लोड हो रहा है...

PI3K/Akt/mTOR inhibitors in breast cancer

Activation of the phosphoinositide 3 kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) pathway is common in breast cancer. There is preclinical data to support inhibition of the pathway, and phase I to Ⅲ trials involving inhibitors of the pathway have been or are being conducted in solid tumors...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Joycelyn JX Lee, Kiley Loh, Yoon-Sim Yap
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: China Anti-Cancer Association 2015-12-01
श्रृंखला:Cancer Biology & Medicine
विषय:
ऑनलाइन पहुंच:http://www.cancerbiomed.org/index.php/cocr/article/view/888
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!